Oxylabs bets $3.6bn valuation on agentic AI web data infrastructure thesis

Oxylabs UAB, the Vilnius-based web data infrastructure company founded in 2015, has secured a $130 million minority investment from Warburg Pincus at a valuation of approximately $3.6 billion. The transaction, disclosed on 9 July 2026, marks the first external capital raise in the company’s 11-year history and is being deployed through the Warburg Pincus Capital Solutions Founders Fund, a hybrid vehicle that closed with more than $4 billion in commitments in September 2024. The deal recasts a business that began as a premium proxy provider into a positioning play on the infrastructure layer of the emerging agentic AI economy. The unresolved question is whether that repositioning can defend a valuation built on a data collection segment still shaped by evolving legal, technical and competitive risks.

What does the Warburg Pincus investment actually change for Oxylabs after a decade of bootstrapped growth?

Oxylabs has scaled to a stated customer base of more than 350,000 without institutional equity capital, which places the current transaction in an unusual category. A minority raise of $130 million at a $3.6 billion valuation implies external ownership of roughly 3.6 percent on a fully primary basis, though the disclosure does not confirm the precise stake, the split between primary and secondary consideration, or the governance terms attached to the WPCS FF investment.

Chief Executive Officer Vytautas Savickas said the proceeds will be used to accelerate development of agentic web search infrastructure and product capabilities. Chief Financial Officer Jurgis Gabrielius Rudgalvis added that the company plans to expand its global network and strengthen its technology stack. The company has not disclosed a specific breakdown between growth investment, network expansion, potential acquisitions or founder liquidity.

Warburg Pincus Capital Solutions is explicitly mandated to combine growth capital with balance sheet optimisation and shareholder liquidity, according to the firm’s own disclosure. That structure suggests the transaction may include a partial secondary component, which would be consistent with a decade-old founder-controlled European technology business seeking early liquidity while retaining operational control. Without further disclosure, the split between primary growth funding and secondary shareholder liquidity remains uncertain, and it is a distinction that materially changes how the injection should be interpreted.

Why has Warburg Pincus routed the Oxylabs deal through its Capital Solutions Founders Fund rather than a conventional growth vehicle?

The choice of the Capital Solutions vehicle is significant. Warburg Pincus described WPCS FF at close as a flexible hybrid capital platform that can supply structured equity, preferred instruments or convertible arrangements to founders and existing shareholders. The vehicle sits alongside the firm’s core private equity, real estate and growth strategies, which together account for a stated $105 billion in assets under management and more than 225 active portfolio companies.

This deployment path signals that the Oxylabs commitment is likely structured differently from a conventional minority growth cheque. Capital Solutions transactions frequently combine preferred equity or convertible features with governance rights that protect the investor without requiring majority ownership. For Oxylabs, this route preserves founder control while formalising an institutional cap table for the first time. For Warburg Pincus, it establishes a foothold in a European data infrastructure asset without the full commitment required of a buyout or a traditional growth-fund deployment.

The advisor lineup reinforces the sophistication of the structure. Goldman Sachs Bank Europe SE acted as sole placement agent, with Deloitte Lithuania advising Oxylabs on financial and tax matters and Tegos and Norton Rose Fulbright serving as its legal counsel across US and Netherlands jurisdictions. Lazard advised Warburg Pincus, with Latham & Watkins LLP, Freshfields and Sorainen providing legal counsel. A cross-border, multi-jurisdictional structure of this depth typically accompanies preferred equity or convertible instruments rather than plain common stock, and the depth of the tax and structuring work implied by the advisor mandate is consistent with a hybrid instrument.

How does the $3.6 billion valuation compare with the wider web data infrastructure and AI enablement market?

The $3.6 billion valuation places Oxylabs among the most highly valued private companies in the web data and proxy infrastructure category. Business News Today did not identify a directly comparable listed peer at that scale, since the segment is dominated by private operators, but adjacent public reference points offer partial context. Enterprise AI data infrastructure and vector database companies have attracted valuations of similar magnitude in recent private rounds, while general listed data platform companies trade at revenue multiples that vary widely by growth rate and gross margin.

The company has not published revenue, gross margin, retention or cash generation figures alongside the announcement, and Warburg Pincus has not disclosed the multiples on which the transaction is based. That leaves external observers unable to independently reconcile the valuation with operating fundamentals. Any characterisation of the price as attractive or stretched must therefore be treated as scenario-based rather than empirically validated.

What the transaction does establish is a marker. It sets a private-market anchor for the web data infrastructure segment at a moment when institutional interest in AI enablement layers, model context sourcing and agent-facing infrastructure has intensified. Where a subsequent listing or secondary transaction lands relative to this benchmark will be a meaningful signal for the segment as a whole.

What competitive position does Oxylabs hold in the crowded web intelligence and proxy services segment?

Oxylabs competes in a market that includes Bright Data, Zyte, Smartproxy, ScraperAPI, NetNut and a long tail of specialist providers. The segment has consolidated around a smaller group of infrastructure-scale operators over the past three years, driven by rising compliance costs, growing enterprise procurement standards and the operational demands of serving high-volume AI training and inference workloads.

Oxylabs points to its Fortune 500 customer base, patent portfolio and repeated inclusion in the Financial Times FT 1000 fastest-growing companies list as evidence of scale and durability. Warburg Pincus Principal Allison Ross referenced the sophistication of the technology and the reach of the network as reasons for the commitment. Neither party disclosed named customer references or contract concentration data.

The competitive question is whether Oxylabs can sustain a differentiated position as AI model providers, hyperscalers and specialist data vendors build in-house web data acquisition capabilities. Anthropic, OpenAI, Google DeepMind and several open source model developers have all invested in proprietary data pipelines. Bright Data, which competes directly with Oxylabs at the top of the market, has publicly stated ambitions in the same agentic infrastructure category. The capital raise gives Oxylabs additional resources to defend its position, but the underlying market dynamics remain fluid, and a premium valuation limits the tolerance for missteps in the next 18 to 24 months.

Why is agentic AI the strategic thesis Oxylabs and Warburg Pincus are betting on for the next capital cycle?

The strategic thesis articulated by Savickas centres on a specific claim about the future of AI. He argued that static indexes, which historically powered search engines, will not be sufficient for autonomous AI agents interacting with the live web at scale. On this view, the infrastructure that grounds AI systems in real-time, uninterrupted access to the open web becomes a foundational layer of the technology stack.

This thesis is the operative logic behind the deal. If AI agents are set to conduct high-frequency interactions with the web on behalf of users, the volume of automated web traffic will grow substantially, and the infrastructure required to acquire, structure and deliver that data to models will scale alongside it. Warburg Pincus is effectively underwriting a view that this infrastructure layer will accrue durable economic value, in the same way that content delivery networks captured value during the growth of internet video.

The counter-argument is that AI model providers may vertically integrate data acquisition capabilities, that regulators may constrain automated data collection more tightly than the current environment allows, or that the addressable market for agentic web access may develop more slowly than optimistic projections suggest. None of these outcomes are certain, but each represents a live risk that the current valuation does not appear to fully discount.

What regulatory and ethical questions could shape the durability of the Oxylabs data infrastructure model?

Large-scale web data collection sits inside an evolving legal and regulatory environment. Court rulings in the United States, notably the hiQ Labs v LinkedIn line of cases, have offered partial protection for scraping of publicly accessible data, but no bright-line rule governs the practice globally. The European Union’s Digital Services Act, the Artificial Intelligence Act, and national data protection regulators continue to refine how automated data acquisition intersects with privacy, competition and platform terms of service.

Oxylabs has publicly positioned itself as a compliant and ethical operator, and its jurisdictional base in Lithuania places it within the European Union’s regulatory perimeter. Warburg Pincus’s willingness to invest at this valuation implies a view that the regulatory environment will remain broadly workable for compliant large-scale data infrastructure providers. That view is defensible, but it is a view rather than a settled fact.

For institutional observers, the material questions are whether platform-level counter-measures against automated collection accelerate, whether the AI Act or subsequent regulation introduces licensing or attestation requirements for training data providers, and whether major content platforms secure new legal or technical tools to control access. Any of these developments would reshape the operating economics of the segment.

How should institutional observers weigh the execution risks facing Oxylabs after this $130 million capital injection?

The most immediate execution question is whether Oxylabs can convert a decade of bootstrapped operational learning into scaled product development for the agentic AI segment. The company has articulated a strategy but has not yet disclosed the specific product roadmap or the revenue mix expected from agentic use cases relative to established proxy and web intelligence services.

Institutional cap table entry also introduces new governance dynamics. Founder-controlled European technology businesses that receive their first outside capital often face adjustments in reporting cadence, board composition and capital allocation discipline. How Oxylabs manages those adjustments will affect how quickly the new capital translates into commercial output.

A further consideration is talent. Scaling in the AI infrastructure segment requires competing for engineering, machine learning and go-to-market talent against well-funded incumbents. The Warburg Pincus commitment provides the resources to compete, but talent markets in Vilnius, London, New York and other relevant hubs remain tight, and execution will depend on the company’s ability to attract senior operators without diluting the compliance culture that underpins the current customer proposition.

Key takeaways from the Oxylabs Warburg Pincus $130 million data infrastructure investment

• Oxylabs UAB has secured a $130 million minority investment from Warburg Pincus at a $3.6 billion valuation, marking the company’s first external capital raise since founding in 2015.
• The commitment is being made through the Warburg Pincus Capital Solutions Founders Fund, a $4 billion hybrid vehicle that can supply structured equity, preferred instruments and founder liquidity.
• The advisor lineup, involving Goldman Sachs, Lazard, Deloitte Lithuania, Norton Rose Fulbright, Latham & Watkins, Freshfields, Tegos and Sorainen, points to a sophisticated cross-border structure that may include preferred or convertible features.
• Oxylabs has not disclosed revenue, margin, retention or cash generation metrics, leaving the $3.6 billion valuation externally unverified against operating fundamentals.
• The strategic thesis is that agentic AI will require real-time, live web data infrastructure that Oxylabs believes it is uniquely positioned to supply at scale.
• The company competes with Bright Data, Zyte, Smartproxy, ScraperAPI and NetNut in a segment where AI model providers may progressively vertically integrate data acquisition.
• The regulatory environment, including the European Union’s Digital Services Act and the Artificial Intelligence Act, remains a live variable that could reshape the economics of the segment.
• The transaction sets a private-market benchmark for the web data infrastructure category at a moment of intense institutional interest in AI enablement layers.
• The proximate execution tests are the pace of agentic AI product development, retention of the existing enterprise base and disciplined use of the fresh capital.
• The most meaningful next signal will be any subsequent revenue disclosure, secondary transaction or public listing that either validates or challenges the $3.6 billion benchmark.